More on CYTK
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $77.90 |
|
|||
| Open | $73.88 | ||||
| 52 Wk High | $13.18 | ||||
| 52 Wk Low | $6.00 | ||||
| Day High | $74.42 | ||||
| Day Low | $71.66 | ||||
| P/E | N/A | ||||
| EPS | $-1.24 | ||||
| Volume | 4,361,475 | ||||
- Form 8-K CYTOKINETICS INC For: Aug 28
- Cytokinetics aficamten meets dual endpoints in non-obstructive HCM trial
- Cytokinetics Announces Positive Results from ACACIA-HCM Presented in Hot Line Session at the European Society of Cardiology (ESC) Congress 2026 and Published in The New England Journal of Medicine
- Cytokinetics Announces Upcoming Presentations at the European Society of Cardiology (ESC) Congress 2026
- Form 4 CYTOKINETICS INC For: Aug 18 Filed by: Malik Fady Ibraham
- Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Form 8-K CYTOKINETICS INC For: Aug 13
- H.C. Wainwright Reiterates Buy Rating on Cytokinetics (CYTK)
- Form SCHEDULE 13G/A CYTOKINETICS INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
- Cytokinetics sues Bristol-Myers Squibb over aficamten patent dispute
Entities mentioned with CYTK
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- PDUFA | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- AdCom | View Related Stories »
- Show More...
